Report Detail

Other Global Blood Transfusion Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3439301
  • |
  • 26 May, 2020
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

This report covers market size and forecasts of Blood Transfusion Diagnostics, including the following market information:
Global Blood Transfusion Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Blood Transfusion Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Blood Transfusion Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Blood Transfusion Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio, DiaSorin (American Standard Companies), Beckman Coulter, Diagast, Abbott, BAG Health Care, Quidel, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology

Based on the Application:
Hospitals
Clinics
Blood Banks
Laboratories
Other


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Blood Transfusion Diagnostics Industry
  • 1.7 COVID-19 Impact: Blood Transfusion Diagnostics Market Trends
  • 2 Global Blood Transfusion Diagnostics Quarterly Market Size Analysis

    • 2.1 Blood Transfusion Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Blood Transfusion Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Blood Transfusion Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Blood Transfusion Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Blood Transfusion Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Blood Transfusion Diagnostics Market
    • 3.4 Key Players Blood Transfusion Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Blood Transfusion Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 ELISA
      • 1.4.2 NAT
      • 1.4.3 Western Blot Assays
      • 1.4.4 Fluorescence Assay
      • 1.4.5 Other Technology
    • 4.2 By Type, Global Blood Transfusion Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Blood Transfusion Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Blood Banks
      • 5.5.4 Laboratories
      • 5.5.5 Other
    • 5.2 By Application, Global Blood Transfusion Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Blood Transfusion Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Grifols
      • 7.1.1 Grifols Business Overview
      • 7.1.2 Grifols Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.1.3 Grifols Blood Transfusion Diagnostics Product Introduction
      • 7.1.4 Grifols Response to COVID-19 and Related Developments
    • 7.2 Thermo Fisher Scientific
      • 7.2.1 Thermo Fisher Scientific Business Overview
      • 7.2.2 Thermo Fisher Scientific Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Product Introduction
      • 7.2.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.3 Roche
      • 7.3.1 Roche Business Overview
      • 7.3.2 Roche Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Roche Blood Transfusion Diagnostics Product Introduction
      • 7.3.4 Roche Response to COVID-19 and Related Developments
    • 7.4 bioMérieux
      • 7.4.1 bioMérieux Business Overview
      • 7.4.2 bioMérieux Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.4.3 bioMérieux Blood Transfusion Diagnostics Product Introduction
      • 7.4.4 bioMérieux Response to COVID-19 and Related Developments
    • 7.5 Bio-Rad
      • 7.5.1 Bio-Rad Business Overview
      • 7.5.2 Bio-Rad Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.5.3 Bio-Rad Blood Transfusion Diagnostics Product Introduction
      • 7.5.4 Bio-Rad Response to COVID-19 and Related Developments
    • 7.6 Ortho Clinical Diagnostics
      • 7.6.1 Ortho Clinical Diagnostics Business Overview
      • 7.6.2 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Product Introduction
      • 7.6.4 Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
    • 7.7 Becton Dickinson
      • 7.7.1 Becton Dickinson Business Overview
      • 7.7.2 Becton Dickinson Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Becton Dickinson Blood Transfusion Diagnostics Product Introduction
      • 7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
    • 7.8 Fujirebio
      • 7.8.1 Fujirebio Business Overview
      • 7.8.2 Fujirebio Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.8.3 Fujirebio Blood Transfusion Diagnostics Product Introduction
      • 7.8.4 Fujirebio Response to COVID-19 and Related Developments
    • 7.9 DiaSorin (American Standard Companies)
      • 7.9.1 DiaSorin (American Standard Companies) Business Overview
      • 7.9.2 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.9.3 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Product Introduction
      • 7.9.4 DiaSorin (American Standard Companies) Response to COVID-19 and Related Developments
    • 7.10 Beckman Coulter
      • 7.10.1 Beckman Coulter Business Overview
      • 7.10.2 Beckman Coulter Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.10.3 Beckman Coulter Blood Transfusion Diagnostics Product Introduction
      • 7.10.4 Beckman Coulter Response to COVID-19 and Related Developments
    • 7.11 Diagast
      • 7.11.1 Diagast Business Overview
      • 7.11.2 Diagast Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.11.3 Diagast Blood Transfusion Diagnostics Product Introduction
      • 7.11.4 Diagast Response to COVID-19 and Related Developments
    • 7.12 Abbott
      • 7.12.1 Abbott Business Overview
      • 7.12.2 Abbott Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.12.3 Abbott Blood Transfusion Diagnostics Product Introduction
      • 7.12.4 Abbott Response to COVID-19 and Related Developments
    • 7.13 BAG Health Care
      • 7.13.1 BAG Health Care Business Overview
      • 7.13.2 BAG Health Care Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.13.3 BAG Health Care Blood Transfusion Diagnostics Product Introduction
      • 7.13.4 BAG Health Care Response to COVID-19 and Related Developments
    • 7.14 Quidel
      • 7.14.1 Quidel Business Overview
      • 7.14.2 Quidel Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.14.3 Quidel Blood Transfusion Diagnostics Product Introduction
      • 7.14.4 Quidel Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      Summary:
      Get latest Market Research Reports on Blood Transfusion Diagnostics. Industry analysis & Market Report on Blood Transfusion Diagnostics is a syndicated market report, published as Global Blood Transfusion Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Blood Transfusion Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,250.00
      $4,875.00
      $6,500.00
      2,505.75
      3,758.63
      5,011.50
      2,996.50
      4,494.75
      5,993.00
      497,997.50
      746,996.25
      995,995.00
      273,357.50
      410,036.25
      546,715.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report